Transcriptome analysis and studies of the differentiation capacities of CD34+ and CD34− AML LSCs revealed that progenitor as well as mature cells may serve as the origin of LSCs, through an acquired ability to self-renew [64,65,66,67]. This evidence concerns the gene CD34 and acute myeloid leukemia.